These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14248511)

  • 1. A CONTROLLED STUDY OF FLUPHENAZINE ENANTHATE IN CHRONIC SCHIZOPHRENIC PATIENTS.
    RAVARIS CL; WEAVER LA; BROOKS GW
    Dis Nerv Syst; 1965 Jan; 26():33-9. PubMed ID: 14248511
    [No Abstract]   [Full Text] [Related]  

  • 2. A DOUBLE BLIND STUDY OF FLUPHENAZINE ENANTHATE.
    BARSA JA; SAUNDERS JC
    Dis Nerv Syst; 1965 Aug; 26():496-8. PubMed ID: 14337143
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluphenazine enanthate in sesame oil, a depot preparation.
    Rasmussen OS
    Acta Psychiatr Scand; 1970; 46(3):311-8. PubMed ID: 5490593
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ; Saxena B; Foley P; Grof P
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

  • 6. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
    Kane J; Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
    Deverteuil R; Lehmann HE; Ban TA; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):219-22. PubMed ID: 5550418
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICAL EXPERIMENTATION OF S. 62-2 (APROPOS OF 40 OBSERVATIONS)].
    WAREMBOURG H; JAILLARD J
    Lille Med; 1964 Dec; 9():962-7. PubMed ID: 14260271
    [No Abstract]   [Full Text] [Related]  

  • 11. The prolonged action of fluphenazine enanthate in oil after depot injection.
    Laffan RJ; High JP; Burke JC
    Int J Neuropsychiatry; 1965 Aug; 1(4):300-6. PubMed ID: 5863505
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F; Verité P; André D; Colonna L; Boucly P
    Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FACTORS INFLUENCING THE CLINICAL RESPONSES OF SCHIZOPHRENIC PATIENTS TO PHENOTHIAZINE DRUGS AND TO PLACEBO.
    KLERMAN GL; DAVIDSON EM; KAYCE MM
    Psychiatr Res Rep Am Psychiatr Assoc; 1964 Dec; 19():97-115. PubMed ID: 14232660
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA; Aderounmu AF
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM; Wyman SM
    Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLINICAL TRIAL OF FLUPHENAZINE ENANTHATE-- A LONG-ACTING INJECTABLE TRANQUILIZER.
    POLLACK SL; TOURLENTES TT; ZOCCHI AF
    Am J Psychiatry; 1964 Jul; 121():73-4. PubMed ID: 14154789
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic trial with a long-acting phenothiazine derivative. Fluphenazine enanthate in a group of chronic schizophrenics].
    Mariátegui J; Alarcón R; Arana J; Azcárate C; Butler A
    Rev Neuropsiquiatr; 1966 Mar; 29(1):33-44. PubMed ID: 5940303
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.